Details for New Drug Application (NDA): 071285
✉ Email this page to a colleague
NDA 071285 describes TRIMIPRAMINE MALEATE, which is a drug marketed by Breckenridge, Elite Labs Inc, and Usl Pharma, and is included in five NDAs. It is available from three suppliers. Additional details are available on the TRIMIPRAMINE MALEATE profile page.
The generic ingredient in TRIMIPRAMINE MALEATE is trimipramine maleate. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the trimipramine maleate profile page.
The generic ingredient in TRIMIPRAMINE MALEATE is trimipramine maleate. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the trimipramine maleate profile page.
Summary for 071285
| Tradename: | TRIMIPRAMINE MALEATE |
| Applicant: | Usl Pharma |
| Ingredient: | trimipramine maleate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 071285
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 100MG BASE | ||||
| Approval Date: | Dec 8, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
